| Literature DB >> 27354072 |
Huaqiong Zhou1, Phillip R Della2, Pamela Roberts2, Louise Goh2, Satvinder S Dhaliwal2.
Abstract
OBJECTIVE: To update previous systematic review of predictive models for 28-day or 30-day unplanned hospital readmissions.Entities:
Keywords: EPIDEMIOLOGY; PUBLIC HEALTH
Mesh:
Year: 2016 PMID: 27354072 PMCID: PMC4932323 DOI: 10.1136/bmjopen-2016-011060
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Characteristics of 49 included studies on 28-day or 30-day unplanned hospital readmission (UHR) predictive models
| Reference | Model name | Model outcome | Study design/data source | Sample size | Age group (years) | Duration of retrieved data source | Readmission rate |
|---|---|---|---|---|---|---|---|
| Escobar | ED 30 | 30-day all-cause readmissions | Retrospective cohort | A total of 360 036 patients | Mean=64.1 | 1 June 2010–31 December 2013 | Derivation: 12.5%; Validation: 12.4% |
| Yu | Institution-specific prediction model | 30-day all-cause readmission | Retrospective cohort | Hospital 1=2441 | ≥65 | Not reported | H1=23% |
| Baillie | Prediction model | 30-day all-cause readmissions | Retrospective and prospective cohort | Retrospective: 120 396 discharges | Not reported—adult | August 2009–September 2012 | Retrospective: 14.4%; Prospective: 15.1% |
| Choudhry | ACC Admission and Discharge model | 30-day all-cause readmissions | Retrospective cohort | A total of 126 479 patients | Mean=66.01 (readmission) | 1 March 2010–31 July 2012 | 7.25% |
| Gildersleeve and Cooper | Risk of readmission score (RRS) | 30-day all-cause readmission | Retrospective cohort | Derivation: 8700 patients | Mean=60.6 | 2010 | 14.1% |
| Validation: 8189 patients | Mean=65 | 2011 | 14.8% | ||||
| Kruse | Unnamed | 30-day all-cause readmission | Retrospective cohort | 463, 351 Index admissions | ≥18 | 1 October 2008–31 August 2010 | 9.7% |
| Richmond | Unnamed | 30-day all-cause readmission for patients≥65 years | Retrospective cohort | 4717 patients split into a derivation (80%) and validation sample (20%) | Mean=77.27 | January 2010–December 2012 | 14.4% |
| Shulan | Unnamed | 30-day all-cause readmission | Retrospective cohort | 8718 patients | Mean=67.04 (UHRs); 66.43 (no UHRs) | 2011 | 16.2% |
| van Walraven | LACE+ (extension of a validated index) | 30-day all-cause readmission | Retrospective cohort | 499 996 patients/858 410 index hospitalisations | >18 | 2004–2009 | 11.8% |
| Cotter | LACE index (validation) | 30-day all-cause readmission | Retrospective cohort | 507 patients | Mean=85 | 2010 | 17.8% |
| Regression model | Retrospective cohort | 502 patients (validation cohort) | 14.8% | ||||
| Khan | Rehospitalisation Risk Score | 30-day all-cause readmission | Retrospective cohort | 227 patients | Average=79 | Single day on 26 January 2011 | 15% |
| Lee | Unnamed | 28-day all-cause readmission | Retrospective cohort | 11 951 patients | Ranged from 0 to 70+ | 2009 | 28.9% |
| van Walraven | CMG score (case-mix groups) | 30-day all-cause readmission | Retrospective cohort | Random 200 000 patients of 3 277 033 | Mean age of | 1 April 2003–31 March 2009 | 6.8% |
| LACE index (validation) | |||||||
| Combined CMG score and LACE index | |||||||
| van Walraven | LACE+ | 30-day all-cause readmission | Retrospective cohort | Random 500 000 of 3 277 033 patients then 1/2 derivation and ½ validation | Mean=57.9 (derivation); 57.9 (validation) | 1 April 2003–31 March 2009 | 14% |
| Hebert | CHF model | 30-day readmission on | Retrospective cohort | A total of 3968 patients | Mean=61 | 1 August 2009–31 July 2011 | 16.2% |
| Historical validation: 1756 | 1 August 2008–31 July 2009 | 17.7% | |||||
| Random sample: 396 | 16.2% | ||||||
| Iannuzzi | Vascular surgery readmission risk score | 30-day readmission on patients after vascular surgery | Retrospective cohort | 24 929 patients | Mean=69.5 (UHRs); 69.7 (no UHRs) | 2011 | 10.1% |
| Keyhani | CMS-based model | 30-day readmission on patients with stroke | Retrospective cohort | 3436 patients | Mean=69.5 (UHRs); 66.9 (no UHRs) | 2007 | 12.8% |
| CMS-based model plus social Risk factors | |||||||
| CMS-based model plus social risk and clinical factors | |||||||
| Rana | Electronic medical record (EMR) model | 30-day readmission on ischaemic heart disease of patients after AMI | Retrospective cohort | 1660 AMI admissions | Mean=67.8 (derivation cohort); validation cohort: 68.4 | January 2009–December 2011 | 6.3% |
| HOSPITAL score (validation) | |||||||
| Comorbidities (validation) | |||||||
| Shahian | Unnamed | 30-day readmission post coronary artery bypass grafting | Retrospective cohort | 162 572 admissions | ≥65 | 2008–2010 | 12.6–23.6% |
| Shams | Potentially avoidable readmission (PAR) | 30-day avoidable readmission on pneumonia/HF/AMI/ | Retrospective cohort | 5600 admissions | HF: mean=71.3 (PAR); vs 68.6 (no UHRs) | 2011–2012 | 13.09% |
| Internal validation | |||||||
| External validation | 478 patients | August and September 2012 | |||||
| CMS endorsed model (validation) | 30-day readmission | ||||||
| Sharif | Unnamed | 30-day readmission on patients aged 40–64 years with COPD | Retrospective cohort | 8263 patients | Mean=57 (UHRs); no UHRs—age not reported | January 2009–November 2011 | 8.9% |
| Lucas | Complex all-variable model; parsimonious readmission score | 30-day readmissions on patients post general, vascular, and thoracic surgery | Retrospective cohort | A total of 230 864 patients | Median=56 | 2011 | 5–16% across surgical specialties |
| Wallmann | Unnamed | 30-day readmission on cardiac-related disease | Retrospective cohort | 35 531 admissions | Mean=67.9 | 2003–2009 | Derivation: 4.4%; Validation: 4.7% |
| Wasfy | Risk score for 30-day readmission after PCI (parsimonious) | 30-day readmission after percutaneous coronary intervention | Retrospective cohort | 36 060 surviving to discharge | Mean=68.1 (UHRs); 64.3 (no UHRs) | 1 October 2005–30 September 30 2008 | 10.4% |
| Krumholz | Claims model | 30-day readmission on acute myocardial infarction (AMI) | Retrospective cohort | Derivation cohort: 100 465 | Mean=78.7 | Half of 2006 | 18.9% |
| Medical record model | Derivation cohort: 130 944 | 2005 and half of 2006 | 19.96% | ||||
| Betihavas | Unnamed | 28-day readmission on patients with chronic heart failure | Retrospective cohort | 280 patients | Mean=69 (no UHRs); 79 (UHRs) | Not reported | 13% |
| Di Tano | Unnamed | 30-day readmission on acute HF | Prospective cohort | 1520 patients | Mean=72 | Not reported | 6.25% |
| Huynh | The non-clinical model | 30-day readmission on HF | Retrospective cohort | Non-clinical—1537 patients | Mean=80 | 2009–2012 | 25.4% |
| Raposeiras-Roubin | GRACE risk score | 30-day readmission on HF after acute coronary syndrome | Retrospective cohort | 4429 patients | Mean=77 (UHRs); 68 (no UHRs) | 2004–2010 | 1.3% |
| Sudhakar | Readmission Risk score | 30-day readmission on patients with CHF | Retrospective cohort | 1046 admissions from 712 patients | Mean=65.2 | September 2011–August 2013 | 35.28% |
| Fleming | Unnamed | 30-day readmission on patients with HF | Retrospective cohort | 3413 admissions | Mean=74 (derivation cohort); validation cohort: 74.6 | 1 October 2007–30 August 2011 | 24.2% (derivation) |
| Wang | LACE index (validation) | 30-day readmission on patients with CHF | Retrospective cohort | 253 patients | Mean: 57.67 (no UHRs); 56.17 (UHRs) | June 2012–June 2013 | 24.5% |
| Eapen | Unnamed | 30-day readmission on heart failure | Retrospective cohort | 33 349 patient | Median=80 | 1 January 2005–31 December 2009 | 22.8% |
| Zai | The telemonitoring-based readmission model; the psychosocial readmission model (validation) | 30-day readmission on heart failure | Retrospective cohort | 100 patients | Average age of 66.8 | July 2008–November 2011 | 38% |
| Au | Five administrative data-based models: Charlson; CMS Krumholz | 30-day readmission on HF | Retrospective cohort | 59 652 patients | Mean=76 | April 1999 and 2009 | 19% |
| Watson | The psychosocial readmission model | 30-day readmission on HF | Retrospective cohort | 729 | Mean=71.4 | 1 October 2007–30 September 2008 | 13.3% (all female) |
| Mather | Hartford Hospital model | 30-day readmission on pneumonia | Retrospective cohort | 956 index admissions | ≥65 | January 2009–March 2012 | 15.5% |
| Lindenauer | Administrative claims model | 30-day readmission on pneumonia | Retrospective cohort | Derivation cohort: 226 545 | Mean=80 | Half of 2006 | 17.4% |
| Medical record model | 47 429 cases | Half of 2006 and 2005 | 17.0% | ||||
| Shadmi | Preadmission Readmission Detection Model | 30-day readmission on medical patients | Retrospective cohort | Total: 33 639 admissions | Mean=68.2; 67.5 (no UHRs); 72.5 (UHRs) | 1 January 2010–31 March 2010 | 16.8% |
| Tsui | Unnamed | 28-day readmission on elderly medical patients | Retrospective cohort | Total: 327 529 episodes | ≥65 | Derivation: 2005 | 7.8% |
| Donzé | Unnamed | 30-day readmission on medical patients due to end-of-life care | Retrospective cohort | 10 275 admissions | Mean=61.5 (no UHRs); 60.8 (potentially avoidable readmissions (PARs) | 1 July 2009–30 June 2010 | Total:22.3%; 8%—PARs |
| He | Unnamed | 30-day readmission on medical patients and chronic pancreatitis (CP) | Retrospective cohort | Medical patients: 26 091 (JHH)+16 194 (BMC) | Mean=50.3 (JHH) | Medical patients: January 2012–April 2013; | 11.5% (JHH) |
| Patients with CP: 3218 (JHH)+706 (BMC) | Mean age: 51.4 (JHH) | CP discharged from January 2007–April 2013 | 15.6% (JHH) | ||||
| Taha | Readmission Risk Score (RRS) | 30-day readmission on general internal medicine services | Retrospective cohort | 858 index hospitalisations | Mean=54 (derivation); validation cohort: 54 | 1 April 2010–30 June 2010 | 16% |
| Donzé | HOSPITAL score | 30-day readmissions on general medical patients | Retrospective cohort | 10 731 discharges | Mean=61.3 | 1 July 2009–30 June 2010 | 8.5% |
| Tan | LACE index (validation) | 30-day readmission on general medical patients | Retrospective | 127 550 patients | ≥21 | 1 January 2006–31 December 2010 | 4.87–18.43% |
| Billings | PARR-30 | 30 days readmission on general medical patients | Retrospective cohort | 576 868 admissions | Adult | 1 April 2008 and 31 March 2009 | 12.2% |
| Zapatero | SEMI INDEX | 30-day readmission on general medical patients | Retrospective cohort | Derivation cohort: 999 089 patients; Validation cohort: 510 588 patients (internal) | Median=70 for two cohorts | January 2006–December 2007 | 12.4% |
| 2008 | 12.5% | ||||||
| Gruneir | LACE index (validation) | 30-day readmission on general medical patients | Retrospective cohort | 26 045 patients | 18–105 | 2007 | 12.6% |
| Singal | Unnamed | 30-day readmissions on patients with cirrhosis | Retrospective cohort | A total of 838 patients with 1291 admissions | Mean=52.5 | January 2008–December 2009 | 27% |
| Volk | Cirrhosis readmission prediction model | 30-day readmission on cirrhosis | Retrospective cohort | 402 patients | ≥18 | 1 July 2006–1 July 2009 | 41%, 22% of which are PARs |
| Perkins | Unnamed | 30-day readmission on patients with CKD second to HF | Retrospective cohort | 607 patients with chronic kidney disease | Mean=72.3 (UHRs); 74.1 (no UHRs) | 1 July 2004–28 February 2010 | 19.1% |
| Nijhawan | Unnamed | 30-day readmission on HIV-infected patients | Retrospective cohort | 2402 index admissions randomly split (1/2) into derivation vs validation | Mean=43 | March 2006–November 2008 | 24.4% |
| Whitlock | Unnamed | 30-day readmission on acute pancreatitis | Retrospective cohort | Derivation cohort: 248 | Mean=51.6 derivation | 1 June 2005–31 December 2007 | 19% |
| Taber | 30DRA with fixed variable vs 30DRA with fixed variables and dynamic clinical data | 30-day readmission on patients following kidney transplantation | Retrospective cohort | 1147 patients Derivation; internal validation using random iteration of 50% sampling | Mean=51 (no UHRs); 52 (UHRs) | 2005–2012 | 11% |
| Lawson | Unnamed | 30-day readmission on patients following colectomy | Retrospective cohort | 12 981 patients | ≥65 | 2005–2008 | 13.5% |
| Iannuzzi | Endocrine surgery Readmission Risk Score | 30-day readmission on patients following cervical endocrine operations | Retrospective cohort | 34 046 cases | Mean=54 (no UHRs); 55 (UHRs) | 2011–2012 | 2.8% |
| Mesko | Unnamed | 30-day readmission on total hip and knee arthroplasty | Retrospective cohort | 1291 admissions/1236 patients | Mean=65.6 (UHRs); 68.3 (no UHRs) | 1 May 2010–30 April 2011 | 3.6% |
| Moore | Unnamed (quality indicator based) | 30-day readmission on trauma | Retrospective cohort | 57 524 patients | ≥16 | 1 April 2005–28 February 2010 | 6.6% |
| Graboyes | Unnamed | 30-day readmission on otolaryngology patients | Retrospective cohort | 1058 patients—1271 hospital admissions | Mean=52 (no UHRs); 56 (UHRs) | 1 January 2011–31 December 2011 | 7.3% |
| Vigod | READMIT (41 points) | 30-day readmission after discharge from acute psychiatric units | Retrospective cohort | Derivation: 32 749 patients | Median=41 (UHRs); 44 (no UHRs) | 1 April 2008–31 March 2011 | 8.42–10% |
ACS, acute coronary syndrome; AMI, acute myocardial infarction; AP, acute pancreatitis, CHF, congestive heart failure; CKD, chronic kidney disease; COPD, common obstructive pulmonary disease; EMRs, electronic medical records; GRACE, global registry of acute coronary events; HF, heart failure; PCI, percutaneous coronary intervention; PREADM, preadmission readmission detection model; PNA, peptide nucleic acid.
Performance of predictive models for 28-day or 30-day unplanned hospital readmissions (UHRs)
| Reference | Model name | Discrimination (ROC) | Calibration (H&L) | Threshold (%) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) |
|---|---|---|---|---|---|---|---|---|
| Escobar | ED 30 | Validation: 0.739 | 0.40 | ≥20 | ||||
| Discharge 30 | Validation: 0.756 | 0.60 | ||||||
| LACE (validation) | Validation: 0.729 | 0.40 | ||||||
| Yu | Institution-specific prediction model | 0.74 (hospital 2) | ||||||
| LACE (validation) | 0.55 (hospital 2) | |||||||
| Baillie | Prediction model | Retrospective: 0.62 | 40 | 85 | 31 | 89 | ||
| Prospective: 0.61 | 39 | 84 | 30 | 89 | ||||
| Choudhry | ACC Admission Model | Derivation data set: 0.76 | Derivation data set: 36.0 (p<0.001) | 11 | 70 | 71 | ||
| ACC Discharge Model | Derivation data set: 0.78 | Derivation: 31.1 (p<0.001) | 11 | 70 | 71 | |||
| Gildersleeve and Cooper | Risk of readmission score (RRS) | Derivation cohort: 0.74 | 21.6 (p=0.006) | 14 | 74.9 | 54.4 | 22.2 | 92.6 |
| Validation cohort: 0.70 | 79.2 | 55.4 | 22.6 | 94.2 | ||||
| Kruse | Unnamed | Derivation set: 0.668 | ||||||
| Richmond | Unnamed | 0.60 | 47 | 78 | ||||
| Shulan | Unnamed | Derivation cohort: 0.80 | ||||||
| van Walraven | LACE+ (extension of a validated index) | 0.768 (1 hospitalisation per patient) | H–L χ2 50.3 | |||||
| Cotter | LACE index (validation) | 0.55 | ||||||
| Regression model | 0.57 | 47 | 54 | 47 | ||||
| Khan | Rehospitalisation risk score | 19 | 97 | 28 | 19 | 98 | ||
| 21 | 58 | 63 | 21 | 90 | ||||
| 27 | 42 | 81 | 27 | 89 | ||||
| Lee | Unnamed | ROC was graphically illustrated, but no actual number was reported | ||||||
| van Walraven | CMG Score | 0.637 | p=0.0079 | |||||
| LACE index (validation) | 0.72 | P<0.0001 | ||||||
| Combined CMG Score and LACE | 0.743 | p<0.0001 | ||||||
| van Walraven | LACE+ (validation) | 0.743 | ||||||
| LACE+ with CMG score | 0.753 | |||||||
| Hebert | CHF model | Derivation cohort: 0.64–0.73; | p>0.05 | |||||
| Iannuzzi | Vascular surgery readmission risk score | Derivation dataset: 0.67 | 0.09 | |||||
| Keyhani | CMS-based model | 0.636 | 0.866 | |||||
| CMS-based model plus social risk factors | 0.646 | 0.462 | ||||||
| CMS-based model plus social risk and clinical factors | 0.661 | 0.856 | ||||||
| Rana | EMR model | 0.78 | 5 | 65 | 78 | 21 | 83.6 | |
| HOSPITAL score (validation) | 0.60 | 62 | 50 | 13 | 78.9 | |||
| Comorbidities (validation) | 0.53 | 65 | 45 | |||||
| Shahian | Unnamed | 0.648 | ||||||
| Shams | Potentially avoidable readmission (PAR) | Retrospective cohort: 0.836 | 91.95 | 97.65 | 86.61 | 98.65 | ||
| CMS endorsed model (validation) | 0.63 | |||||||
| Sharif | Unnamed (basic model vs final model) | Basic model (patient characteristics only): 0.677; final model (additional provider-level and system-level factors) | ||||||
| Wallmann | Unnamed | 0.75 | 4 | 66 | 70 | 10 | 98 | |
| Wasfy | Risk score for 30-day readmission after PCI (parsimonious) | Validation data set: 0.67 | >24 | |||||
| Lucas | Complex all-variable model | Derivation data set: 0.721 | ||||||
| Parsimonious readmission score | Derivation data set: 0.696 | 1.2 | 100 | 0 | 8 | / | ||
| 2.4 | 99 | 6 | 8 | 99 | ||||
| 4.7 | 92 | 28 | 10 | 98 | ||||
| 8 | 77 | 52 | 12 | 97 | ||||
| 11.8 | 55 | 73 | 15 | 95 | ||||
| 14.6 | 37 | 85 | 17 | 94 | ||||
| 17.2 | 21 | 92 | 19 | 93 | ||||
| 20.3 | 9 | 97 | 21 | 93 | ||||
| 22.2 | 2 | 100 | 22 | 92 | ||||
| 40 | 0 | 100 | 40 | 92 | ||||
| Krumholz | Claims model | Derivation cohort: 0.63 | ||||||
| Medical record model | Derivation cohort: 0.58 | |||||||
| Betihavas | Unnamed | 0.8 | ||||||
| Di Tano | Unnamed | 0.695 | ||||||
| Huynh | The non-clinical model | 0.66 | ||||||
| Raposeiras-Roubin | The GRACE risk score | 0.79 | p=0.83 | 37.9 | 82.5 | 62.8 | 5.6 | 99.1 |
| Sudhakar | Readmission Risk (RR) Score | All age group—0.61 | ≥29 | 33 | 80 | 47 | 69 | |
| ≥24 | 61 | 52 | 41 | 71 | ||||
| ≥21 | 83 | 27 | 38 | 75 | ||||
| Fleming | Unnamed | Derivation cohort: 0.69 | ||||||
| Wang | LACE index (validation) | ≥10 | ||||||
| Eapen | Derivation cohort: 0.59 | |||||||
| Zai | The telemonitoring-based readmission model | 0.21 | 50 | 81 | 61 | 72 | ||
| The psychosocial model (validation) | 0.67 | 87 | 32 | 44 | 80 | |||
| Au | Five administrative data-based models | 0.57–0.61 | ||||||
| Watson | The psychosocial readmission model | 0.67 | ||||||
| Mather | Hartford Hospital model | Derivation data set: 0.71 | p=0.96 | |||||
| Lindenauer | Administrative claims model | 0.63 | ||||||
| CMS medical record model | 0.59 | |||||||
| Shadmi | PREADM | Derivation data set: 0.70 | ||||||
| Tsui | Unnamed | Derivation data set: 0.819 | p<0.05 | |||||
| Donzé | Unnamed | 0.85 | ||||||
Summary of significant variables included in the predictive models for unplanned hospital readmissions (UHRs)
| Reference | Model name | Admitting diagnosis | Admitting ward | Blood transfusion | BMI | Comorbidities | Complications before discharge | Daily living score | Demographic/social | Discharge disposition | Discharge hour | Environment | General anaesthesia | Health insurance | Index type of admission | Injury severity score | Laboratory tests | Length of stay | Physical examinations | Postoperative complications | Medications | Number of previous admission | Number of previous ED presentations | Overall prognosis | Procedures at index admission | Substances usage | Symptoms | Use of outpatient clinic | Vital signs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Escobar | ED 30 and Discharge 30 | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| LACE index (validation) | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||||
| Yu | Institution-specific prediction model | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||
| LACE index (validation) | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||||
| Baillie | Prediction model | ✓ | |||||||||||||||||||||||||||
| Choudhry | ACC Admission and Discharge Model | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||
| Gildersleeve and Cooper | Risk of Readmission Score (RRS) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||
| Kruse | Unnamed | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Richmond | Unnamed | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||
| Shulan | Unnamed | ✓ | ✓ | ✓ | |||||||||||||||||||||||||
| van Walraven | LACE+ (validation) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||
| Cotter | LACE index (validation) | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||||
| Regression model | ✓ | ||||||||||||||||||||||||||||
| Khan | Rehospitalisation Risk Score | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||
| Lee | Unnamed | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||||
| van Walraven | CMG score | ✓ | |||||||||||||||||||||||||||
| LACE (validation) | |||||||||||||||||||||||||||||
| Combined CMG and LACE | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||||
| van Walraven | LACE+ (validation) | ||||||||||||||||||||||||||||
| Combined CMG and LACE+ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||
| Hebert | CHF model | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||
| PNA model | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||||
| AMI model | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||||
| Combined model | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||
| Iannuzzi | Vascular surgery readmission risk score | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||
| Keyhani | CMS-based Model | ✓ | ✓ | ||||||||||||||||||||||||||
| CMS-based Model plus social risk factors | ✓ | ✓ | ✓ | ||||||||||||||||||||||||||
| CMS-based model plus social risk and clinical factors | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||||
| Rana | EMR Model | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||||
| Shahian | Unnamed | ✓ | ✓ | ||||||||||||||||||||||||||
| Shams | PARs | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| CMS endorsed model (validation) | |||||||||||||||||||||||||||||
| Sharif | Unnamed | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Lucas | Complex all-variable model | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||
| Parsimonious readmission score | ✓ | ✓ | |||||||||||||||||||||||||||
| Wallmann | Unnamed | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||||
| Wasfy | Risk score after PCI (parsimonious) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||
| Krumholz | Claims model (administrative) | ✓ | ✓ | ||||||||||||||||||||||||||
| Medical record model | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Betihavas | Unnamed | ✓ | ✓ | ||||||||||||||||||||||||||
| Di Tano | Unnamed | ✓ | ✓ | ✓ | |||||||||||||||||||||||||
| Huynh | Non-clinical model | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||||
| Clinical model | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||||
| Combined model | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Raposeiras-Roubin | The GRACE Risk Score | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Sudhakar | Readmission Risk Score | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||
| Fleming | Unnamed | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||||
| Wang | LACE index (validation) | ||||||||||||||||||||||||||||
| Eapen | Unnamed | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||
| Zai | The telemonitoring based readmission model | ✓ | ✓ | ||||||||||||||||||||||||||
| The psychosocial readmission model (validation) | |||||||||||||||||||||||||||||
| Au | Charlson (validation) | ✓ | ✓ | ||||||||||||||||||||||||||
| CMS Krumholz (validation) | |||||||||||||||||||||||||||||
| Keenan (validation) | ✓ | ✓ | ✓ | ||||||||||||||||||||||||||
| LACE (validation) | |||||||||||||||||||||||||||||
| LACE+ (validation) | |||||||||||||||||||||||||||||
| Watson | The psychosocial readmission model | ✓ | ✓ | ||||||||||||||||||||||||||
| Mather | Hartford Hospital Model | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| CMS Model (validation) | |||||||||||||||||||||||||||||
| Lindenauer | Claims model (administrative) | ✓ | ✓ | ✓ | |||||||||||||||||||||||||
| Medical record model | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Shadmi | PREADM | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||
| Tsui | Unnamed | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Donzé | Unnamed | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||||
| He | Unnamed | ✓ | ✓ | ✓ | |||||||||||||||||||||||||
| Taha | Readmission Risk Score (RRS) | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Donzé | HOSPITAL score | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Tan | LACE index (validation) | ||||||||||||||||||||||||||||
| Billings | PARR-30 | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||||
| Zapatero | SEMI INDEX | ✓ | ✓ | ✓ | |||||||||||||||||||||||||
| Gruneir | LACE index (validation) | ||||||||||||||||||||||||||||
| Singal | Unnamed | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Volk | Cirrhosis readmission prediction model | ✓ | ✓ | ✓ | |||||||||||||||||||||||||
| Perkins | Unnamed | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||
| Nijhawan | Unnamed | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Whitlock | Unnamed | ✓ | ✓ | ✓ | |||||||||||||||||||||||||
| Taber | 30DRA with fixed variable | ✓ | ✓ | ✓ | |||||||||||||||||||||||||
| 30DRA with fixed variable and dynamic clinical data | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||||
| Lawson | Unnamed | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||
| Iannuzzi | Endocrine surgery Readmission Risk Score | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Mesko | Unnamed | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||||||||||||||||||||||
| Moore | Unnamed | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Graboyes | Unnamed | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||||
| Vigod | READMIT | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||||||||||||||||||||
BMI, body mass index; ED, emergency department.
Figure 1Flow chart for the search and study selection process (PRISMA). PRISMA, preferred reporting items for systematic reviews and meta-analyses.
Figure 2Pareto chart of significant variables included in the predictive models. BMI, body mass index; ED, emergency department.
Continued
| Reference | Model name | Discrimination (ROC) | Calibration (H&L) | Threshold (%) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| He | Unnamed | Medical patient | Validation | ||||||||
| Within site | CV on JHH | 0.75 | 21 | 50 | 84 | 29 | 93 | ||||
| CV on BMC | 0.79 | 30 | 50 | 88 | 28 | 95 | |||||
| Across site | Test on BMC | 0.81 | 9 | 47 | 88 | 27 | 95% | ||||
| Test on JHH | 0.78 | 30 | 58 | 76 | 24 | 93 | |||||
| CP | Within site | CV on JHH | 0.71 | 21 | 50 | 68 | 34 | 84 | |||
| CV on BMC | 0.65 | 30 | 56 | 79 | 20 | 955 | |||||
| Across site | Test on BMC | 0.65 | 9 | 85 | 41 | 11 | 97 | ||||
| Test on JHH | 0.73 | 30 | 60 | 71 | 27 | 91 | |||||
| Taha | Readmission Risk Score | 12 | 18 | 95 | |||||||
| 16 | 18 | 90 | |||||||||
| 20 | 20 | 89 | |||||||||
| 24 | 21 | 86 | |||||||||
| 28 | 28 | 85 | |||||||||
| 32 | 38 | 84 | |||||||||
| Donzé | HOSPITAL score | Derivation data set: 0.69 | Derivation data set: p=0.28 | 5.2–18.4 | |||||||
| Tan | LACE index (validation) | 0.70 | 13.1 (p=0.107) | 16 | |||||||
| Billings | PARR-30 | 0.70 | 50 | 5.4 | 99.5 | 59.2 | |||||
| Zapatero | SEMI INDEX | 0.876 | 7.4–22 | ||||||||
| Gruneir | LACE index (validation) | 16 | |||||||||
Continued
| Reference | Model name | Discrimination (ROC) | Calibration (H&L) | Threshold (%) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) |
|---|---|---|---|---|---|---|---|---|
| Singal | Unnamed | Derivation cohort: 0.68 | ||||||
| Volk | Cirrhosis readmission prediction model | 0.65 | ||||||
| Perkins | Unnamed | 0.792 | 20 | 69 | 73.4 | 38.3 | 90.9 | |
| 50 | 28.5 | 97.1 | 70.2 | 85 | ||||
| 80 | 1.7 | 99.8 | 66.7 | 19.1 | ||||
| Nijhawan | Unnamed | Derivation: 0.72 | ||||||
| Whitlock | Unnamed | Derivation cohort: 0.88 | ||||||
| Taber | 30DRA with fixed variable | 0.63 | p=0.061 | 10 | 57.7 | 63.8 | ||
| 30DRA with fixed variable and dynamic clinical data | 0.731 | p=0.603 | 10 | 62.8 | 73.3 | |||
| Lawson | Unnamed | 0.728 | ||||||
| Iannuzzi | Endocrine surgery Readmission risk score | Derivation cohort: 0.676 | p=0.083 | |||||
| Validation cohort: 0.646 | p=0.592 | |||||||
| Mesko | Unnamed | Derivation data set: 0.59 | ||||||
| Moore | Unnamed | 0.651 | Intercept, slope 0.000370; 1.0001 | |||||
| Graboyes | Unnamed | 0.85 | ||||||
| Vigod | READMIT | Derivation data set: 0.631 | p=0.868 | |||||
NPV, negative predictive value; PPV, positive predictive value; ROC, receiver operating characteristic.